Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: A retrospective observational study

BMC Pulmonary Medicine

Volumn 9, Issue , 2009, Pages

  Determann, Rogier M ^a   Millo, Julian L ^b   Waddy, Sam ^b   Lutter, Rene ^a   Garrard, Chris S ^b   Schultz, Marcus J ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c HERMES Critical Care Group   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CLARA CELL PROTEIN; CLARA CELL PROTEIN 16; KREBS VON DEN LUNGEN; MEMBRANE PROTEIN; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BIOLOGICAL MARKER; CLARA CELL SECRETORY PROTEIN; IMMUNOGLOBULIN RECEPTOR; MUC1 PROTEIN, HUMAN; MUCIN 1; UTEROGLOBIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENETIC ASSOCIATION; HUMAN; MALE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TIDAL VOLUME; VENTILATOR ASSOCIATED PNEUMONIA; ACUTE LUNG INJURY; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; RETROSPECTIVE STUDY;

ACUTE LUNG INJURY; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCIN-1; PNEUMONIA, VENTILATOR-ASSOCIATED; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, IMMUNOLOGIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; UTEROGLOBIN;

EID: 73149099650     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-9-49     Document Type: Article

References (37)

1. Klompas M. Does this patient have ventilator-associated pneumonia?. JAMA 2007, 297:1583-1593. 10.1001/jama.297.14.1583, 17426278.
2. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, Lewandowski K, Bion J, Romand J-A, Villar J, Thorsteinsson A, Damas P, Armaganidis A, Lemaire F, . for the ALIVE Study Group Epidemiology and outcome of acute lung injury in European intensive care units: Results from the ALIVE study. Intensive Care Med 2004, 30:51-61. 10.1007/s00134-003-2022-6, 14569423.
3. Girard TD, Bernard GR. Mechanical ventilation in ARDS: a state-of-the-art review. Chest 2007, 131:921-929. 10.1378/chest.06-1515, 17356115.
4. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-1564. 10.1016/S0140-6736(07)60604-7, 17482987.
5. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
6. Ferguson ND, Frutos-Vivar F, Esteban A, Fernández-Segoviano P, Aramburu JA, Nájera L, Stewart TE. Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 2005, 33:2228-2234. 10.1097/01.CCM.0000181529.08630.49, 16215375.
7. Estenssoro E, Dubin A, Laffaire E, Canales HS, Sáenz G, Moseinco M, Bachetti P. Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome. Intensive Care Med 2003, 29:1936-1942. 10.1007/s00134-003-1943-4, 12955187.
8. Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci 2000, 923:68-77.
9. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, Mednick G, Matthay ZA, Matthay MA. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006, 173:1008-1015. 10.1164/rccm.200509-1477OC, 2662912, 16456142.
10. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999, 160:1843-1850.
11. Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, Kohno N, Kotani T, Morisaki H, Takeda J, Nakamura M, Fang X, Martin TR, Matthay MA, Hashimoto S. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2004, 286:L1088-1094. 10.1152/ajplung.00420.2002, 12959931.
12. Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, Hata Y. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 2004, 9:165-174. 10.1111/j.1356-9597.2004.00712.x, 15009093.
13. Hartl D, Griese M. Surfactant protein D in human lung diseases. Eur J Clin Invest 2006, 36:423-435. 10.1111/j.1365-2362.2006.01648.x, 16684127.
14. Kohno N. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. J Med Invest 1999, 46:151-158.
15. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K, . Acute Respiratory Distress Syndrome Network Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003, 58:983-988. 10.1136/thorax.58.11.983, 1746524, 14586055.
16. Lesur O, Langevin S, Berthiaume Y, Legare M, Skrobik Y, Bellemare JF, Levy B, Fortier Y, Lauzier F, Bravo G, Nickmilder M, Rousseau E, Bernard A, . Critical Care Research Group of the Quebec Respiratory Health Network Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome. Intensive Care Med 2006, 32:1167-1174. 10.1007/s00134-006-0235-1, 16794838.
17. Determann RM, Millo JL, Waddy S, Lutter R, Garrard CS, Schultz MJ. Systemic Levels of Surfactant Protein D Reflect the Intensity of Pulmonary Inflammation in Patients with Ventilator-Associated Pneumonia. Am J Respir Crit Care Med 2007, 175:A965.
18. A'Court CH, Garrard CS, Crook D, Bowler I, Conlon C, Peto T, Anderson E. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Q J Med 1993, 86:635-648.
19. Millo JL, Schultz MJ, Williams C, Weverling GJ, Ringrose T, Mackinlay CI, Poll T, Garrard CS. Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia. Intensive Care Med 2004, 30:68-74. 10.1007/s00134-003-2060-0, 14634726.
20. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652. 10.1097/00003246-199510000-00007, 7587228.
21. Afessa B, Gajic O, Keegan MT. Severity of illness and organ failure assessment in adult intensive care units. Crit Care Clin 2007, 23:639-658. 10.1016/j.ccc.2007.05.004, 17900487.
22. Pugin J. Clinical signs and scores for the diagnosis of ventilator-associated pneumonia. Minerva Anestesiol 2002, 68:261-265.
23. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988, 138:720-723.
24. Determann RM, Wolthuis EK, Choi G, Bresser P, Bernard AM, Lutter R, Schultz MJ. Lung epithelial injury markers are not influenced by Use of Lower Tidal Volumes during Elective Surgery in Patients without Pre-existing Lung Injury. Am J Physiol Lung Cell Mol Physiol 2008, 294:L344-350. 10.1152/ajplung.00268.2007, 18083770.
25. Robin M, Dong P, Hermans C, Bernard A, Bersten AD, Doyle IR. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 2002, 20:1152-1161. 10.1183/09031936.02.02042001, 12449168.
26. Shijubo N, Itoh Y, Yamaguchi T, Imada A, Hirasawa M, Yamada T, Kawai T, Abe S. Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. Am J Resp Crit Care Med 1999, 160:930-933.
27. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575. 10.1056/NEJMoa062200, 16714767.
28. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia--a review. Crit Care Med 2006, 34:871-877.
29. Ferguson ND, Davis AM, Slutsky AS, Stewart TE. Development of a clinical definition for acute respiratory distress syndrome using the Delphi technique. J Crit Care 2005, 20:147-154. 10.1016/j.jcrc.2005.03.001, 16139155.
30. Blomberg A, Mudway I, Svensson M, Hagenbjork-Gustafsson A, Thomasson L, Helleday R, Dumont X, Forsberg B, Nordberg G, Bernard A. Clara cell protein as a biomarker for ozone-induced lung injury in humans. Eur Respir J 2003, 22:883-888. 10.1183/09031936.03.00048203, 14680073.
31. Bonetto G, Corradi M, Carraro S, Zanconato S, Alinovi R, Folesani G, Da Dalt L, Mutti A, Baraldi E. Longitudinal monitoring of lung injury in children after acute chlorine exposure in a swimming pool. Am J Respir Crit Care Med 2006, 174:545-549. 10.1164/rccm.200509-1392OC, 1555620,1555620, 16763216.
32. Michel O, Murdoch R, Bernard A. Inhaled LPS induces blood release of Clara cell specific protein (CC16) in human beings. J Allergy Clin Immunol 2005, 115:1143-1147. 10.1016/j.jaci.2005.01.067, 15940126.
33. Bernard AM, Lauwerys RR, Noel A, Vandeleene B, Lambert A. Urine protein 1: a sex-dependent marker of tubular or glomerular dysfunction. Clin Chem 1989, 35:2141-2142.
34. Fartoukh M, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003, 168:173-179. 10.1164/rccm.200212-1449OC, 12738607.
35. Lesur O, Hermans C, Chalifour JF, Picotte J, Lévy B, Bernard A, Lane D. Mechanical ventilationi-induced pneumoprotein CC-16 vascular transfer in rats: effect of KGF pretreatment. Am J Physiol Lung Cell Mol Physiol 2003, 284:L410-419.
36. Wittkowski H, Sturrock A, van Zoelen MA, Viemann D, Poll T, Hoidal JR, Roth J, Foell D. Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome. Crit Care Med 2007, 35:1369-1375. 10.1097/01.CCM.0000262386.32287.29, 17414728.
37. Yan SF, Barile GR, D'Agati V, Du Yan S, Ramasamy R, Schmidt AM. The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complications. Curr Diab Rep 2007, 7:146-153. 10.1007/s11892-007-0024-4, 17425919.